Hannover Attack - Airport Searched
Hannover City, Germany
Posted: 17th, May. 2008
Main contributor - ZWN Field Reporter: Michael Schneider

Related report:
Mortosis incident in Hannover?
'John Doe' identified in Hannover attack
Victim released from hospital

Following last weeks viscous undead attack in the city of Hannover, questions now arise as to how the airport worker (who was subsequently neutralized) contracted the necro-mortosis virus infection.

Authorities have now revealed the undead assailants identification. He was Eugene Becker (33). According to an airport released statement Becker had been employed at Hannover airport since 2003. His job was titled 'cargo plane payload coordinator and handler.'

It has been announced that authorities are sealing the cargo storage area where Becker was assigned to last week. Hazmat officials are concentrating their investigative efforts to the quarantined area in hopes of establishing a root cause of Becker's infection.

Hannover airport remains open at this point to commercial travellers, however, all cargo container shipments are being redirected.

A group of 100 airport staff have established a picket line to protest the vulnerability of it's workers to infection. It is not an official union strike, however Wolfgang Kole, leader of German railways trade union 'Transnet,' is scheduled to hold talks with its members, many whom are to be joining the airport staff in a one day protest on Monday.

In related news, recently released victim Silke Koch has been continuing her recovery at an undisclosed location. The focus of the medical community are firmly fixed on Koch's well being. If she continues to resist mortosis contamination her body may be able to produce antibodies crucial in the development of a vaccination, suppressor or cure.

Amcalon Corporation who's XL-6 inhibitor was used in phase two testing at Hannover hospital is credited with being integral to Koch's remarkable recovery. Stocks in Amcalon have risen sharply since the news last week to a new company high of $87.65 per diluted share.